Allergy Therapeutics (LSE:AGY) Buildings And Improvements : £0.00 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Buildings And Improvements?

Allergy Therapeutics's quarterly buildings and improvements increased from Dec. 2022 (£0.00 Mil) to Jun. 2023 (£11.53 Mil) but then declined from Jun. 2023 (£11.53 Mil) to Dec. 2023 (£0.00 Mil).

Allergy Therapeutics's annual buildings and improvements increased from Jun. 2021 (£8.49 Mil) to Jun. 2022 (£9.92 Mil) and increased from Jun. 2022 (£9.92 Mil) to Jun. 2023 (£11.53 Mil).

Allergy Therapeutics Buildings And Improvements Historical Data

The historical data trend for Allergy Therapeutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Buildings And Improvements Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Buildings And Improvements

Get a 7-Day Free Trial

8.49

9.92

11.53

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial															-	9.92	-	11.53	-

Allergy Therapeutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Allergy Therapeutics (LSE:AGY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines